Literature DB >> 25253966

Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study.

Yan-Ming Zhou1, Xiao-Feng Zhang1, Lu-Peng Wu1, Cheng-Jun Sui1, Jia-Mei Yang1.   

Abstract

AIM: To identify risk factors contributing to the development of combined hepatocellular-cholangiocarcinoma (CHC) in China.
METHODS: One hundred and twenty-six patients with CHC and 4:1 matched healthy controls were interviewed during the period from February 2000 to October 2012. Logistic regression analysis was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for each risk factor.
RESULTS: Univariate analysis showed that the significant risk factors for CHC development were hepatitis B virus (HBV) infection, heavy alcohol consumption, a family history of liver cancer, and diabetes mellitus. Multivariate stepwise logistic regression analysis showed that HBV infection (OR = 19.245, 95%CI: 13.260-27.931) and heavy alcohol consumption (OR = 2.186, 95%CI: 1.070-4.466) were independent factors contributing to the development of CHC.
CONCLUSION: HBV infection and heavy alcohol consumption may play a role in the development of CHC in China.

Entities:  

Keywords:  Alcohol consumption; Combined hepatocellular-cholangiocarcinoma; Epidemiology; Hepatitis B virus; Risk factors

Mesh:

Year:  2014        PMID: 25253966      PMCID: PMC4168099          DOI: 10.3748/wjg.v20.i35.12615

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Xian-Huan Yu; Lei-Bo Xu; Hong Zeng; Rui Zhang; Jie Wang; Chao Liu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-12

2.  Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.

Authors:  Dominique Cazals-Hatem; Sandra Rebouissou; Paulette Bioulac-Sage; Olivier Bluteau; Hélène Blanché; Dominique Franco; Geneviève Monges; Jacques Belghiti; Antonio Sa Cunha; Pierre Laurent-Puig; Claude Degott; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2004-08       Impact factor: 25.083

3.  A clinicopathological study on combined hepatocellular and cholangiocarcinoma.

Authors:  J Taguchi; O Nakashima; M Tanaka; T Hisaka; T Takazawa; M Kojiro
Journal:  J Gastroenterol Hepatol       Date:  1996-08       Impact factor: 4.029

4.  Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.

Authors:  Shun-Ichi Ariizumi; Yoshihito Kotera; Satoshi Katagiri; Masayuki Nakano; Masakazu Yamamoto
Journal:  Ann Surg Oncol       Date:  2011-11-24       Impact factor: 5.344

5.  Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center.

Authors:  Qian Zhan; Bai-Yong Shen; Xia-Xing Deng; Zhe-Cheng Zhu; Hao Chen; Chen-Hong Peng; Hong-Wei Li
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-07       Impact factor: 7.027

6.  Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Jeong-Hoon Lee; Goh Eun Chung; Su Jong Yu; Sang Youn Hwang; Joon Suk Kim; Hwi Young Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Nam-Joon Yi; Kyung-Suk Suh; Kuhn Uk Lee; Ja-June Jang; Yoon Jun Kim
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

7.  Expression of sialyl-Tn, Tn and T antigens in primary liver cancer.

Authors:  M Sasaki; T Yamato; Y Nakanuma
Journal:  Pathol Int       Date:  1999-04       Impact factor: 2.534

8.  Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.

Authors:  K Aoki; K Takayasu; T Kawano; Y Muramatsu; N Moriyama; F Wakao; J Yamamoto; K Shimada; T Takayama; T Kosuge
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

9.  Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver.

Authors:  Atsushi Suzuki; Sayaka Sekiya; Makiko Onishi; Naoko Oshima; Hiroshi Kiyonari; Hiromitsu Nakauchi; Hideki Taniguchi
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

10.  Parallel induction of cell proliferation and inhibition of cell differentiation in hepatic progenitor cells by hepatitis B virus X gene.

Authors:  Jiayi Huang; Lihong Shen; Yongliang Lu; Hongli Li; Xifeng Zhang; Daixi Hu; Tao Feng; Fangzhou Song
Journal:  Int J Mol Med       Date:  2012-07-12       Impact factor: 4.101

View more
  15 in total

1.  Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.

Authors:  Jie-Hui Tan; Wan-Yan Zhou; Lei Zhou; Rong-Chang Cao; Guo-Wei Zhang
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

2.  Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.

Authors:  Linghao Zhao; Yuyouye Wang; Tao Tian; Xinjie Rao; Wei Dong; Jinmin Zhang; Yuan Yang; Qifei Tao; Fang Peng; Chenhang Shen; Songbo Wang; Hui Liu; Xi Zeng; Weiping Zhou
Journal:  Hepatol Int       Date:  2022-09-20       Impact factor: 9.029

Review 3.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

4.  Composite liver tumors: a radiologic-pathologic correlation.

Authors:  Megha Nayyar; David K Imagawa; Temel Tirkes; Aram N Demirjian; Roozbeh Houshyar; Kumar Sandrasegaran; Chaitali S Nangia; Tara Seery; P Bhargava; Joon Ii Choi; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-12

5.  Addition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study.

Authors:  Min Dai; Yue-Wu Yang; Wen-Hai Guo; Feng-Lin Wang; Ge-Min Xiao; Yang-Mei Li; Hong-Zhi Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-24       Impact factor: 2.629

Review 6.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

Review 7.  Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.

Authors:  Shweta Gera; Mark Ettel; Gabriel Acosta-Gonzalez; Ruliang Xu
Journal:  World J Hepatol       Date:  2017-02-28

8.  Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma.

Authors:  Yan-Ming Zhou; Cheng-Jun Sui; Xiao-Feng Zhang; Bin Li; Jia-Mei Yang
Journal:  BMC Gastroenterol       Date:  2017-02-10       Impact factor: 3.067

9.  Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis.

Authors:  Chen-Yang Tao; Wei-Ren Liu; Lei Jin; Zheng Tang; Meng-Xin Tian; Xi-Fei Jiang; Han Wang; Pei-Yun Zhou; Yuan Fang; Zhen-Bin Ding; Yuan-Fei Peng; Zhi Dai; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Ying-Hong Shi
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

10.  Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venanzio Setola; Fabio Sandomenico; Maria Luisa Barretta; Andrea Belli; Raffaele Palaia; Fabiana Tatangelo; Roberta Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Radiol Oncol       Date:  2020-05-28       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.